stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / TNDM / Gross Profit

Tandem Diabetes Care, Inc. Gross Profit 2012–2025

Tandem Diabetes Care, Inc. (TNDM) annual gross profit by fiscal year, computed from SEC filings.

Fiscal yearGross ProfitGross marginChange (YoY)
FY 2025$546.01M53.8%+11.5%
FY 2024$489.57M52.1%+33.1%
FY 2023$367.69M49.2%-11.0%
FY 2022$412.99M51.5%+9.8%
FY 2021$376.21M53.5%+44.4%
FY 2020$260.52M52.2%+34.1%
FY 2019$194.21M53.6%+116.2%
FY 2018$89.82M48.9%+103.7%
FY 2017$44.09M41.0%+86.9%
FY 2016$23.59M28.0%-11.2%
FY 2015$26.58M36.5%+74.3%
FY 2014$15.25M30.7%+147.3%
FY 2013$6.17M21.3%+557.5%
FY 2012$-1.35M-54.5%

Source: Tandem Diabetes Care, Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Tandem Diabetes Care, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Tandem Diabetes Care, Inc. — frequently asked questions

What is Tandem Diabetes Care, Inc.'s gross profit?

Tandem Diabetes Care, Inc. (TNDM) reported gross profit of $546.01M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from Tandem Diabetes Care, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More TNDM financial history

Full TNDM fundamentals page → · All 1,500+ companies →